Sector Expert: Chris Moreau
Christopher Moreau was appointed president and chief executive officer of Miraculins in February 2007. Previous to his appointment, he served as vice-president, business development for Miraculins after joining the company in 2006. Mr. Moreau brings more than 25 years of experience in the areas of business development, financing, sales, marketing and operations management. He has held several senior executive management roles within the telecommunications and manufacturing sectors. Prior to joining Miraculins, Mr. Moreau was the president of Advansis Capital Corp., a privately held Canadian financial services provider.
While other diseases catch headlines and media attention, diabetes has crept quietly into a full-blown, worldwide pandemic. With the Scout DS®, Winnipeg-based Miraculins Inc. is on the leading edge of medical innovation with the world's first noninvasive retail screening test for diabetes. In this interview with The Life Sciences Report, Miraculins President and CEO Christopher Moreau explains how the company is poised to expand into multiple markets to meet a desperate need for diabetes screening in North America and around the world.